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Abstract – N-myristoyltransferase (NMT) attaches a 14 carbon fatty acid, myristic acid, to the N-terminal
glycine residue of proteins. NMT exists in two isoforms NMT1 and NMT2. Myristoylated proteins play
critical roles in protein–protein interactions, cell signaling and oncogenesis. Although elevated expression
of NMT1 has been described in colorectal carcinoma, its expression and roles in normal and inﬂamed lungs
of the cattle are unknown. Therefore, we investigated the expression and activity of NMT in a bovine model
of lung inﬂammation induced with Mannheimia hemolytica and in vitro in neutrophils and macrophages.
Western blots revealed increased expression of NMT1 in lungs from infected animals compared to control
animals. Total NMT activity was reduced in inﬂamed lungs compared to control animals (p < 0.05) along
with increased expression of enolase, a putative inhibitor of NMT. NMT1 staining was observed in the
septum, vascular endothelium and the epithelium in the lungs from control as well as infected calves. NMT1
expression was intense in neutrophils in the necrotic areas in the inﬂamed lungs. Immuno-electron
microscopy localized NMT1 in cytoplasm and nuclei of endothelium, pulmonary intravascular macrophages
and airway epithelium. Total NMT activity and NMT1 expression were increased in neutrophils and
macrophages exposed to Escherichia coli LPS in vitro. NMT knockdown increased apoptosis in activated
neutrophils. This is the ﬁrst report demonstrating expression of NMT in normal and inﬂamed lungs and a
novel role for NMT in regulation of neutrophil lifespan.
NMT / neutrophil / macrophage / apoptosis / RNA knockdown
1. INTRODUCTION
N-myristoylation is a lipidic modiﬁcation
referringtothecovalentattachmentofmyristate,
a14carbonsaturatedfattyacid,totheN-terminal
glycine residue of a number of mammalian,
viral and fungal proteins [3, 6, 19, 25, 28, 32].
Myristoylation of proteins is catalyzed by the
ubiquitously distributed eukaryotic enzyme
N-myristoyltransferase (NMT) which is a
member of GCN5-related N-acetyltransferase
(GNAT) superfamily of proteins. NMT hasbeen
puriﬁedandcharacterizedfromdifferentsources
[3, 6, 19, 25, 28]. The cDNA encoding NMT
from human, yeast, bovine spleen, malaria para-
site and higher plant have been characterized.
NMTinlowereukaryotes is encoded by a single
copy gene whereas higher eukaryotes such
as bovine, human and Arabidopsis NMT
are encoded by two gene copies. The second
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(NMT2) has been cloned from a human liver
libraryandtherespectivemousehomologuesfor
the two human NMT have also been cloned [7].
We demonstrated for the ﬁrst time in a rat
model higher activity of NMTin colonic epithe-
lialneoplasm thanin the normal appearingcolo-
nic tissue, and an increase in NMTactivity at an
early stage in colonic carcinogenesis [14]. Fur-
thermore, we have reported a potential role for
NMT in cardiac muscle in the experimentally
inducedischemia-reperfusion, inParkinsonsyn-
dromeinratmodelandalsointhestreptozotocin
induced diabetic rat [30]. Earlier we demon-
strated an essential role ofNMT1 in early devel-
opment of mice. Although homozygous Nmt
/
mice did not survive, we were able to isolate
homozygous Nmt
/ embryonic stem cells
[37] suggesting NMT1 knock out is not lethal
tocellsurvival.Our recentdataalsoshowedthat
NMT1 is important for the proper differentiation
of monocytes [33]. Taken together, NMT is
emerging as an important regulator of cell sig-
naling in normal, tumor and immune cells.
The expression, activity and role of NMT
have not been demonstrated in acute lung
inﬂammation (ALI). ALI underlies most of the
lung diseases and results in signiﬁcant mortality
and morbidity in humans and domestic animals
and imposes enormous economic burden on the
health care system and animal industry [27, 36].
For example, therapeutic and preventive mea-
sures needed to tackle pneumonia in cattle cost
nearly $1 billion every year in the USA alone
[26]. ALI is characterized by excessive activa-
tion and recruitment of neutrophils and mono-
cytes/macrophages. Activated neutrophils live
longer and cause tissue damage, which is
believedtocontributetomorbidityandmortality
[13, 16, 17]. There is an ongoing search to
explore the role of new molecules to better
understand the pathogenesis of ALI with an
aim to develop more effective therapeutics.
Considering role of NMT in regulating dif-
ferentiation of monocytes [33] and current lack
of any data on the role of NMT1 in bacterial
acute lung inﬂammation, we investigated
the expression and activity of NMT1 in a
calf model of lung inﬂammation induced fol-
lowing intratracheal instillation of Mannheimia
hemolytica [34]. The data from these experi-
ments show that both NMT activity and
NMT1 expression are altered in inﬂamed lungs.
The in vitro data show changes in NMTactivity
in neutrophils upon exposure to lipopolysaccha-
ride (LPS) and the effect of NMT1 expression
on the lifespan of neutrophils.
2. MATERIALS AND METHODS
2.1. Materials
LPS isolated from Escherichia coli 0127.B8 was
purchased from Sigma-Aldrich, St. Louis, USA
(L3129). 9,10
3H-Myristic acid (39.3 Ci/mM) was
purchased from Perkin Elmer (Waltham, USA).
Pseudomonas acyl CoA synthetase was purchased
from ICN Biochemicals (Aurora, USA). PVDF mem-
brane was purchased from BioRad Laboratories
(Mississauga, Canada). NMT1 mAb and HRP-conju-
gated goat anti mouse antibody was obtained from
BD-Biosciences (Mississauga, Canada). Gold conju-
gated anti rabbit secondary antibody was procured
fromBritishBiocellInternational.Polyclonal(Cardiff,
UK) antibody was raised against puriﬁed NIP71 in
New Zealand white rabbits and its speciﬁcityhas been
describedpreviously[20].Cellculturereagents,RPMI
1640, and fetal bovine serum were purchased from
Invitrogen/GIBCO (Burlington, Canada). Disposable
plastic tissue culture plates and other supplies were
from VWR Canlab (Mississauga, Canada). Chemilu-
minescence reagent plus was obtained from NEN Life
Science products (Boston, USA). Peptide substrate
based on the N-terminal ends of pp60
c-Src
(GSSKSKPKR) was synthesized by the Alberta Pep-
tide Institute, Edmonton, Canada. PMA and general
laboratory reagents of analytical grade were obtained
from Sigma Chemical Co. (Oakville, Canada).
2.2. Tissue samples
Lung tissue samples were obtained as described
earlier[34].Brieﬂy,4to6weekoldmaleHolstein-Frie-
siancalveswereinfectedintratracheallywithM.hemol-
ytica A1 (20 · 10
9 CFU in 10 mL volume) or with
endotoxin-free saline. This strain of M. hemolytica
was isolated from a calf lung in 1982 at the Vaccine
and Infectious Disease Organization (University of
Saskatchewan, Saskatoon, Canada). Lung samples
were collected according to a pre-determined plan
which included dividing the each lung lobe into 10
arbitrary slices and collecting a piecefrom the 5thslice
of each lobe. Lung samples were frozen for protein
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orforimmuno-goldelectronmicroscopy.Whileimmu-
nohistology was performed on sections prepared from
lung tissues obtained from all the animals,the Western
blotsandotheranalysesweredoneonlungsamplestis-
sues from only three animals each of the groups.
2.3. Homogenization
Tissue samples from infected (n = 3) and control
animals (n = 3), that were previously stored at
80  C were used for the experiment. Using a poly-
tron homogenizer, 1 g of each tissue sample collected
from an animal was homogenized together at 4  Ci n
2 mL of phosphate buffered saline (PBS) containing
0.1 mM EGTA and 10 mM 2-mercaptoethanol.
Samples were homogenized twice for 30 s each with
a cooling interval of 1 min and centrifuged at 400 g
for 15 min. The supernatant was removed and used
for biochemical studies.
2.4. Cell culture
Promonocytic U937 cell line was obtained from
ATCC and grown in RPMI 1640 supplemented with
10% fetal calf serum, 1% antibiotic solution in a
humidiﬁed air and 5% CO2 at 37  C. Cells were
induced to differentiate in to macrophage by the treat-
ment of PMA (10 ng/mL) for 96 h and treated LPS
for indicated dose and time period. Cells were lysed
in RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate,
0.1% SDS) containing 10 mM DTT, 1 mM PMSF
and 1% protease inhibitor cocktail.
2.5. Neutrophil isolation and treatment
Polymorphonuclear leukocytes (PMN) were iso-
lated from the blood collected from healthy cattle
by density gradient centrifugation with lymphocyte
separation media (LSM, MP Biomedicals, Solon,
USA) after using ammonium chloride for erythrocyte
lysis. Isolated cells were suspended in RPMI 1640
medium modiﬁed with 10% fetal bovine serum and
L-glutamine. The viability of isolated PMN was
found to be greater than 97% with trypan blue
(Sigma, St. Louis, USA) exclusion. Neutrophils pur-
ity determined by staining cytospin slides with Grun-
wald Giemsa stain was more than 90%.
2.6. N-myristoyltransferase assay
N-myristoyltransferase activity was assayed as
described earlier [11, 24]. Brieﬂy,
3H-myristoyl-
CoA was synthesized according to the literature
[24]. The reaction was carried out for 30 min at
30  C in a mixture that contained 40 mM Tris-HCl,
pH 7.4, 0.1 mM EGTA, 10 mM MgCl2,5 m M
ATP, 1 mM LiCoA, 1 lM
3H-myristic acid (7.5 lCi)
and 0.3 unit/mL Pseudomonas acyl-CoA synthetase
in a total volume of 200 lL. The conversion to
3H-myristoyl-CoA was generally greater than 95%.
The assay mixture contained 40 mM Tris-HCl,
pH7.4, 0.5 mM EGTA, 0.45 mM 2-mercaptoethanol,
1% Triton X-100, peptide substrate (500 lM) and
NMTsource in a total volume of 25 lL. The transfer-
ase reaction was initiated by adding freshly generated
3H-myristoyl-CoA, allowed to proceed at 30  Cf o r
30 min, terminated by spotting 15 lL aliquots of
incubation mixture onto P81 phosphocellulose paper
discs and drying under a stream of warm air. The P81
phosphocellulose paper discs were washed in two
changes of 40 mM Tris-HCl, pH 7.3 for 60 min.
The radioactivity was quantiﬁed in 7.5 mL of Beck-
man Ready Safe Liquid Scintillation mixture in a
Beckman Liquid Scintillation Counter. One unit of
NMT activity was expressed as 1 pmol of myristoyl
peptide formed per min.
2.7. Western blot
Western blot analysis was performed as described
previously [35]. Equal amount of tissue homogenates
(25 lg) were electrophoresed on a SDS-PAGE and
transferred to a PVDF membrane. Transblotted
PVDF membrane was incubated with blocking buffer
(PBS-Tween 20 plus 5% powdered milk) for 1 h at
room temperature to block non-speciﬁc binding.
After washing, the blots were probed with antibodies
listed in Table I. HRP-conjugated secondary antibod-
ies were used and the bands were detected using the
chemiluminescence reagent plus and exposed to
X-ray ﬁlms.
2.8. Immunohistochemistry
The method has been described previously [31].
Brieﬂy, the sections were deparafﬁnzed, rehydrated
followed by quenching of endogenous tissue peroxi-
dase. The sections were incubated with pepsin
(2 mg/mL 0.01 N HCl) for 45 min followed by BSA
for 30 min. Lung sections were stained with poly-
clonal anti-NMT1 antibody (1:100) for 1 h, HRP con-
jugated anti-rabbit secondary antibody for 30 min
followed by color development. Controls included
omission of primary antibody.
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Thin sections were labeled for immuno-gold elec-
tron microscopy as reported previously [32]. To sum-
marize, 1 lm thick sections stained with toluidine
blue were examined to select desirable areas for ult-
ramicrotomy. Thin sections (90 nm) were collected
on 200 mesh nickel grids, blocked with albumin,
and exposed to a polyclonal NMT antibody (1:50)
for 60 min. The grids were washed with tris-buffered
saline and then incubated with gold conjugated
anti-rabbit secondary antibody (1:100) for 60 min.
Lung sections stained with only secondary antibody
conjugated to gold particles were used as the con-
trols. The sections were stained with 2% aqueous ura-
nyl acetate with triton-X and lead citrate followed by
examination in a Philips 410LS electron microscope
at 60 kV.
2.10. RNA interference
Small interfering RNA (siRNA) duplexes
designed against human NMT1 and NMT2 were
obtained from Dharmacon, Inc. (Lafayette, CO,
USA). Scrambled siRNA from Dharmacon was used
as the control siRNA. siRNA were transfected into
cells by DharmaFect4. Neutrophils (10
4/well) were
plated in 96 well plate, treated with 1 lg/mL
E. coli LPS and lipid mediated transfections were
performed. We mixed 10
5 neutrophils, 50 lL
(2 mM siRNA), 4 mL DharmaFECT 1 in 146 mL
of OptiMEM media according to procedures pro-
vided by Dharmacon. Thereafter, they were allowed
to incubate in a humidiﬁed air and 5% CO2 at
37  C for 18 h. The transfected cells were placed
in a 96 well plate and MTT (3-(4,5-Dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide, a tetra-
zole) assay was performed to determine cell death
after siRNA treatment.
2.11. Other methods
Proteins were estimated by the Bradford method.
The group comparisons were done with Student t-test
with SigmaPlot software and p < 0.05 was accepted
as a signiﬁcant value.
3. RESULTS
3.1. N-myristoyltransferase activity in normal
and inﬂamed lungs
NMT activity was determined in homoge-
nates of the lung samples collected from the
control or the infected calves as described in
theMaterials andMethods section. Interestingly,
NMT activity was signiﬁcantly reduced in the
lungs of the infected animals compared to the
controls (Fig. 1A). Control animals had a mean
activity of 0.0181 pmol/mg/mL, while the mean
activity of NMT within infected animal tissue
was found to be 0.00403 pmol/mg/mL.
3.2. N-myristoyltransferase protein expression
in lungs
Reduced NMT activity in the infected lungs
could be due to the overall reduction in the
NMT expression as a result of infection. There-
fore, we examined the levels of protein expres-
sion in control and infected lung homogenates.
Western blot analysis (Fig. 1B) revealed that
infection of lung with M. hemolytica altered the
expression level of NMT. Contrary to lower
activity of NMT in infected bovine lungs, the
protein expression was high in infected lung
homogenates compared to that of control ones.
This suggests that reduced NMT activity may
be due to the presence of NMTinhibitor(s). Ear-
lier, we discovered an N-myristoyltransferase
inhibitor protein with a molecular mass of
71 kDa (NIP71) from bovine brain and later on
we reported additional inhibitors of NMT.
Therefore, we examined the presence of NMT
Table I. Antibodies used in the present study.
Antibody Clone designate Speciﬁcity Source
NMT1 Monoclonal Human, rat, mouse and bovine BD Biosciences Canada
NIP71 Polyclonal Human, rat, mouse, chicken and bovine [20]
Enolase Monoclonal Human, rat, mouse and bovine BD Biosciences Canada
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and infected lung homogenates. We observed a
polypeptidebandonWesternblotcorresponding
to 48 kDa and band densitometry showed that
this peptide had higher expression in infected
lung homogenates compared to control lung
homogenate(Fig.2).Earlier,wehavediscovered
that boiled sample of enolase with 48 kDa
molecular mass is a potent inhibitor NMT.
EnolasecrossreactswithNIP71polyclonalanti-
body, therefore, we further conﬁrmed that
48 kDa polypeptide band is in fact enolase by
probing with monoclonal anti-enolase antibody.
3.3. Immunocytochemical expression
of N-myristoyltransferase-1
Lung sections from uninfected calves
showed normal histology while those from the
infected animals showed inﬂammation includ-
ing accumulation of inﬂammatory cells in alve-
oli and septa (Figs. 3A and 3B). Some of
the lung sections contained large necrotic areas
that were densely packed with leukocytes.
Tissues stained without primary antibody
lacked any staining (Fig. 3C)w h i l et h o s ew i t h
von Willebrand antibody delineated lung vascu-
lature (Fig. 3D). Lung sections from the control
as well as infected animals showed mild NMT
staining in the septum (Fig. 3E), vascular
Figure 2. NIP expression in bovine lung homog-
enates: proteins (25 lg) from control or infected
bovine lung homogenates were subjected to 10%
SDS-PAGE, transblotted onto PVDF membrane
and was probed with (A) polyclonal anti-NIP
antibody (1:1 000 dilutions) or (B) monoclonal
anti-enolase (1:1 000 dilutions). 1, 2 and 3 are
control whereas, 4, 5 and 6 are infected lungs. (C)
Band intensity analysis (p = 0.01816). Band den-
sity was measured using NIH Image program.
Figure 1. NMT in bovine lung homogenates: (A)
NMTactivitywasdeterminedincontrolandinfected
bovinelunghomogenatesdescribedinMaterialsand
Methodssectionusingpeptidesubstratebasedonthe
N-terminal ends of pp60
c-Src (GSSKSKPKR). Val-
ues are mean of at least three independent experi-
ments ± standard deviation (p = 0.00146). (B)
NMT1 expression in bovine lung homogenates.
Western blot analysis was carried out as described in
Materials and Methods section. Band density was
measured using NIH Image program.
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shown). Some of the leukocytes in the necrotic
areas in the inﬂamed lungs showed ampliﬁed
expression of NMT1 (Fig. 3F).
3.4. Immunogold electron microscopy
NMT1 antibody labeled capillary endothe-
lium (Fig. 4A), pulmonary intravascular
macrophages (Fig. 4B) and airway epithelium
(data not shown) of control and inﬂamed lungs.
Nuclear labeling with NMT1 in lung cells
(Fig. 4B) appeared to be increased in pulmon-
ary intravascular macrophages in tissues from
infected calves (Fig. 4C). Lung sections stained
with only secondary antibody attached to gold
particles did show only occasional gold particle
(data not shown).
Figure 3. HistopathologyandNMT1expression:lungsectionsfromcontrolcalves(A)showednormaltissue
architecture (arrow) while those from the infected calves (B) showed extensive inﬂammation (arrow).
Lung sections stained with only secondary antibody (C) did not show any staining while von Willebrand
Factor antibody (D) reacted with vascular endothelium (single arrow) but not bronchiolar epithelium (double
arrows).Lungsectionsfromcontrolcalves(E)showedlightstainingforNMTinalveolarseptabutthestaining
was intense in neutrophils (F) in inﬂamed lung. Note NMT staining nuclei and cytoplasm of neutrophils
(inset). Original magniﬁcation · 100. (A color version of this ﬁgure is available at www.vetres.org.)
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macrophages and neutrophils
Peripheral blood neutrophils were treated
with E. coli LPS in vitro and NMT activity
assessed at various time points. Following
an initial increase, NMT activity decreased
after 60 min (Fig. 5A). We differentiated
U937 promonocytic cells into monocytes/mac-
rophages by PMA assessed, NMT activity
Figure 4. Immuno-electron microscopy for NMT: NMT was localized in lung capillary endothelium (A)
and pulmonary intravascular macrophages (B). Figure C shows higher magniﬁcation view to demonstrate
extensive nuclear staining for NMT. E: endothelium; AS: alveolar space; N: nucleus; L: lysosome; original
magniﬁcation · 10 000.
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cated concentrations and time periods
(Fig. 5B). Although NMT activity increased
with the increasing concentrations over the
short-term treatment with LPS, prolonged
treatment with LPS did not have a signiﬁcant
effect on NMT activity (Fig. 5B). These results
are similar to those observed in neutrophils.
Immuno-histochemistry showed increased
expression of NMT1 in LPS-treated neutro-
phils (Fig. 6). Furthermore, we determined
the expression proﬁle of NMT1 in PMA
induced U937 cells treated with LPS at vari-
ous concentrations and time points by Western
blot analysis. As shown in Figure 7, short-term
(1 h), but not long-term, treatment of the
cells with increasing concentrations of LPS
enhanced expression of NMT1. Expression
of NIP71, which is an inhibitor of NMT activ-
ity, was not altered upon short and long term
LPS treatment suggesting that LPS activated
NMT in a time dependent manner.
3.6. N-myristoyltransferase activity
and neutrophil apoptosis
Activated neutrophils live longer through
suppression of their constitutive apoptosis.
Because of previously reported roles of NMT1
and NMT2 in the cell survival and embryogen-
esis, we investigated the role of NMT1 in neu-
trophil lifespan by knocking down NMT1. As
depicted in Figure 8 NMT1 or NMT2 knock-
down in neutrophils in the presence or absence
of LPS induced ca 30% cell death compared
to percent control (scramble siRNA).
4. DISCUSSION
Wereportherefortheﬁrsttimetheexpression
and activity of NMTin bacterial lung inﬂamma-
tion, phagocytic cells and the putative roles of
NMT1 in regulation of neutrophil lifespan.
We found that NMT activity was reduced but
protein expression of NMT1 was apparently
increasedininﬂamedlungscomparedtothecon-
trols.NMT1activitywastransientlyincreasedin
LPS-treated neutrophils and macrophages. Fur-
thermore, a knock-down of NMT1 resulted in
increased cell death in normal and LPS-treated
neutrophils.
Total NMT activity in control lung homoge-
nates was four fold higher than that in the
infectedlung homogenates. Interestingly, immu-
nohistologyandWesternblotsshowedanappar-
ent increase in expression of NMT in normal
and inﬂamed lungs. The increased expression
of NMT1 observed is due to the infection and
not due to the bacteria because bacteria lack
NMT gene.Therefore,it is possible that reduced
activity of NMT may be due to endogenous tis-
sue inhibitor(s) and not due to the dilution of the
NMT protein because expression of many other
Figure 5. NMT activity in phagocytic cells: NMT
activity was determined using peptide substrate
based on the N-terminal ends of pp60
c-Src
(GSSKSKPKR) in (A) neutrophils isolated from
peripheral blood of control animals as described in
Materials and methods section and were treated for
indicated time points with LPS (10 lg/mL), and
(B) PMA induced differentiated U937 cells treated
with LPS (open bar, 1 lg/mL and closed bar,
10 lg/mL) for indicated time points.
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homogenates which corresponds to a recently
described NMT inhibitor in boiled supernatant
of enolase [8, 12, 31]. Enolase is a glycolytic
enzyme with a molecular weight of 48 kDa
which catalyzes the reversible removal of a
water molecule from 2-phohosphoglycerate to
yield phosphoenolpyruvate. Enolase is a potent
inhibitor of N-myristoylation in vitro. A c–c
isoform of enolase called neuron-speciﬁc eno-
lase is a putative marker of small cell lung carci-
noma [18]. Our study does not address the
mechanisms or effects of increased expression
of NMT inhibitor on lung inﬂammation. The
data, however, indicate alteration of NMTactiv-
ity in bacterial lung inﬂammation. Based on
our siRNA mediated knockdown experiments
and previous studies [33], we speculate that
increased activity of NMT activity may impact
longevity of inﬂammatory cells such as neutro-
phils in inﬂamed lungs.
Immunohistology revealed light staining for
NMT1 in the lung parenchyma of both experi-
mental groups. We made another interesting
observation with immuno-electron microscopy
that NMT1 is predominantly localized in nuclei
of leukocytes in inﬂamed lungs. Although
NMT shuttles between cytoplasm and the
nucleus in cardiac cells following ischemia
and reperfusion, our recent data show its pre-
dominant nuclear localization in the bone mar-
row cells of colon cancer patients compared to
cytoplasmic localization in the cells from
healthy subjects [22, 33]. Previously, we have
reported nuclear localization of inﬂammatory
proteins such as Toll-like receptor 4 and inte-
grin avb3 in leukocytes and endothelial cells
in inﬂamed lungs [9, 10]. The consequences
of nuclear migration of NMT are not known.
Because NMT impacts the fundamental cell
Figure 6. NMT1staininginneutrophils:nostaining
was observed in neutrophils stained with only
secondary antibody (A). Control neutrophils (B)
showedlightNMT1staining.IntenseNMT1staining
was noticed in neutrophils incubated with LPS for
30 min (C) and in neutrophils stained with NMT1
30 min after 5 min LPS exposure. (A color version
of this ﬁgure is available at www.vetres.org.)
Figure 7. NMT1 expression in phagocytic cells:
NMT1 expression was determined by Western
analysis in PMA induced differentiated U937 cells
treated with LPS with indicated doses and time
points (antibody dilution, 1:1 000).
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possible that NMT shuttles between cytoplasm
and nucleus depending upon the demand for
the myristoylation of cytoplasmic or nuclear
proteins involved in such processes [2, 15].
We also observed strong expression of NMT
in cytoplasm and nuclei of leucocytes trapped
in necrotic areas in the inﬂamed lungs as well
as LPS-treated neutrophils in vitro. It is known
that most of recruited leukocytes in inﬂamed
lungs are activated and that activated leukocytes
live longer [13]. Although activated neutrophils
are necessary to combat bacterial infection, they
also contribute to tissue damage, morbidity and
mortality [17]. Recently, we have demonstrated
that NMT1 and regulated total NMT activity is
essential for the development of myeloid line-
age [33] and it is implicated in regulation of cell
cycle [5]. Therefore, increased expression of
NMT in recruited leukocytes in inﬂamed lungs
and the LPS-activated neutrophils may inhibit
their apoptosis and prolong their lifespan.
W em o v e dt oi nv i t r os e t t i n gt oe x a m i n e
expression and activity of NMT in normal
and LPS-treated neutrophils and macrophages.
The data showed that LPS treatment increased
NMT activity in neutrophils and U937 macro-
phage cells. While the short-term treatment
showed a dose-dependent increase in NMT
activity, the long-term treatment did not have
a similar effect. In contrast to the in vivo data,
we did not ﬁnd any change in the expression
of NMT inhibitor called NIP. Nevertheless,
the increased activity of NMT in neutrophils
and macrophages parallels the data of increased
NMT expression in inﬂamed lungs. This sug-
gests that increased expression of NMT in the
homogenates is potentially due to its over
expression in recruited neutrophils, monocytes
and macrophages and the reduction in total
NMT activity is due to the expression of inhib-
itor protein in other cell types. We assessed the
role of NMT1 in neutrophil apoptosis because
of the previously reported increased expression
of NMT in colorectral carcinoma and its poten-
tial role as a regulator of cell cycle [21, 23,
29, 37]. We found that the NMT knockdown
resulted in 30% reduction in the lifespan of
normal and activated neutrophils. The regula-
tion of neutrophils lifespan is complex and is
Figure 8. MTT Assay: neutrophil survival assay was carried out as described in Material and Methods
section. Neutrophils were incubated with or without LPS (10 lg/mL) and transfected with siRNA against
NMT1 (white) or NMT2 (black). Controls were transfected with scrambled siRNA (grey). Data presented
are from three sets of experiments. The percent cell death was calculated by compared the siRNA
transfected cells with those transfected with scrambled siRNA.
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their products such as LPS [1, 4]. Our data
showing increased activity of NMTand expres-
sion of NMT1 in activated neutrophils and their
reduced lifespan following NMT1 knockdown
provide novel insights in the role of NMT1 in
regulation of neutrophil life.
In conclusion, the data reported in this man-
uscript show expression of NMT1 in endothe-
lium, epithelium and macrophages in both
normal and inﬂamed lungs in a bovine model
of pneumonia. However, NMT activity was
signiﬁcantly reduced due to the increased
expression of NMT inhibitor protein in the
inﬂamed lungs. In phagocytic cells NMT is
activated upon LPS treatment. This is the ﬁrst
report wherein NMT knock down in neutro-
phils resulted in cell death suggesting involve-
ment of NMT in neutrophils activation. Detail
studies are in progress to further elucidate the
NMT mediated activation of neutrophils.
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